Generation Bio Stock Forecast, Price & News

Generation Bio (NASDAQ:GBIO) Frequently Asked Questions

Is Generation Bio a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Generation Bio in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Generation Bio stock.
View analyst ratings for Generation Bio or view top-rated stocks.

When is Generation Bio's next earnings date?

Generation Bio is scheduled to release its next quarterly earnings announcement on Thursday, March 17th 2022.
View our earnings forecast for Generation Bio.

How were Generation Bio's earnings last quarter?

Generation Bio Co. (NASDAQ:GBIO) posted its earnings results on Wednesday, November, 10th. The company reported ($0.56) EPS for the quarter, missing the consensus estimate of ($0.54) by $0.02.
View Generation Bio's earnings history.

What price target have analysts set for GBIO?

4 brokerages have issued 12-month price targets for Generation Bio's shares. Their forecasts range from $39.00 to $50.00. On average, they anticipate Generation Bio's share price to reach $43.50 in the next year. This suggests a possible upside of 194.3% from the stock's current price.
View analysts' price targets for Generation Bio or view top-rated stocks among Wall Street analysts.

Who are Generation Bio's key executives?

Generation Bio's management team includes the following people:

• Dr. Cameron Geoffrey McDonough, Pres, CEO, Sec. & Director (Age 51, Pay $856.88k)
• Dr. Matthew Norkunas M.B.A., M.D., Chief Financial Officer (Age 43, Pay $357.65k)
• Dr. Tracy Zimmermann Ph.D., Chief Devel. Officer (Age 51, Pay $507.92k)
• Dr. Robert Kotin Ph.D., Co-Founder & Advisor (Age 65)
• Dr. Matthew Stanton Ph.D., Chief Scientific Officer (Age 48)
• Dr. Jennifer Elliott Esq., J.D., Ph.D., Chief Legal Officer
• Mr. Phillip Samayoa Ph.D., Sr. VP & Head of Corp. Devel.
• Ms. Sara Den Besten, Chief People Officer
• Dr. Douglas Kerr M.B.A., M.D., Ph.D., Chief Medical Officer (Age 54)
• Ms. Antoinette Paone M.B.A., M.S., Sr. VP & Head of Regulatory Affairs and Quality

Who are some of Generation Bio's key competitors?

Some companies that are related to Generation Bio include Zentalis Pharmaceuticals (ZNTL), 23andMe (ME), ACADIA Pharmaceuticals (ACAD), Arcus Biosciences (RCUS), Galapagos (GLPG), Insmed (INSM), Hypera (HYPMY), Arena Pharmaceuticals (ARNA), Dicerna Pharmaceuticals (DRNA), Cytokinetics (CYTK), Intra-Cellular Therapies (ITCI), Cryoport (CYRX), Amicus Therapeutics (FOLD), Prestige Consumer Healthcare (PBH) and Reata Pharmaceuticals (RETA).
View all of GBIO's competitors.

What other stocks do shareholders of Generation Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Generation Bio investors own include DocuSign (DOCU), NVIDIA (NVDA), Overstock.com (OSTK), Boeing (BA), Pure Storage (PSTG), Mastercard (MA), QUALCOMM (QCOM), Riot Blockchain (RIOT), Twilio (TWLO) and Enphase Energy (ENPH).

When did Generation Bio IPO?

(GBIO) raised $126 million in an initial public offering on Friday, June 12th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, Jefferies and Cowen served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

What is Generation Bio's stock symbol?

Generation Bio trades on the NASDAQ under the ticker symbol "GBIO."

Who are Generation Bio's major shareholders?

Generation Bio's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (5.50%), Bellevue Group AG (4.35%), Carmignac Gestion (2.59%), Casdin Capital LLC (2.33%), Victory Capital Management Inc. (2.24%) and Geode Capital Management LLC (1.39%). Company insiders that own Generation Bio stock include Donald William Nicholson, Douglas Kerr, Evan Spiegel, Geoff Mcdonough, James E Flynn, Jason P Rhodes, Matthew Stanton and Venture Associates X L Atlas.
View institutional ownership trends for Generation Bio.

Which institutional investors are selling Generation Bio stock?

GBIO stock was sold by a variety of institutional investors in the last quarter, including Casdin Capital LLC, Ensign Peak Advisors Inc, Citigroup Inc., Marshall Wace LLP, Voloridge Investment Management LLC, Goldman Sachs Group Inc., Laurion Capital Management LP, and Rafferty Asset Management LLC. Company insiders that have sold Generation Bio company stock in the last year include Douglas Kerr, Evan Spiegel, Geoff Mcdonough, Jason P Rhodes, Matthew Stanton, and Venture Associates X L Atlas.
View insider buying and selling activity for Generation Bio or view top insider-selling stocks.

Which institutional investors are buying Generation Bio stock?

GBIO stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Geode Capital Management LLC, Victory Capital Management Inc., Dimensional Fund Advisors LP, SG Americas Securities LLC, Bank of New York Mellon Corp, Martingale Asset Management L P, and Cubist Systematic Strategies LLC. Company insiders that have bought Generation Bio stock in the last two years include Donald William Nicholson, and James E Flynn.
View insider buying and selling activity for Generation Bio or or view top insider-buying stocks.

How do I buy shares of Generation Bio?

Shares of GBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Generation Bio's stock price today?

One share of GBIO stock can currently be purchased for approximately $14.78.

How much money does Generation Bio make?

Generation Bio has a market capitalization of $841.13 million. The company earns $-80.52 million in net income (profit) each year or ($2.10) on an earnings per share basis.

How many employees does Generation Bio have?

Generation Bio employs 100 workers across the globe.

What is Generation Bio's official website?

The official website for Generation Bio is generationbio.com.

Where are Generation Bio's headquarters?

Generation Bio is headquartered at 301 BINNEY STREET, CAMBRIDGE MA, 02142.

How can I contact Generation Bio?

Generation Bio's mailing address is 301 BINNEY STREET, CAMBRIDGE MA, 02142. The company can be reached via phone at 617-655-7500 or via email at [email protected].